Compounds > topotecan
Page last updated: 2024-08-24

topotecan and Neuroendocrine Tumors

topotecan has been researched along with Neuroendocrine Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ananda, S; Khasraw, M; Michael, M1
Boyd, M; Mairs, RJ1

Reviews

2 review(s) available for topotecan and Neuroendocrine Tumors

ArticleYear
Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.
    Expert review of anticancer therapy, 2016, Volume: 16, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Diagnostic Imaging; Gastrointestinal Neoplasms; Humans; Molecular Targeted Therapy; Neuroendocrine Tumors; Radiotherapy; Streptozocin; Topotecan

2016
Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy.
    Nuclear medicine and biology, 2008, Volume: 35 Suppl 1

    Topics: 3-Iodobenzylguanidine; Bystander Effect; Combined Modality Therapy; Humans; Neuroendocrine Tumors; Radiopharmaceuticals; Radiotherapy Dosage; Topotecan

2008